Mind is a leading mental health charity in England and Wales and has produced information on many areas of mental health. This Mind factsheet looks at understanding addiction and dependency. It also provides references for further reading and a list of useful organisations.
Report that aims to provide information and evidence to support the development of services for young people experiencing problems due to their own problematic drugs and/or substance misuse.
The guide focuses on the needs of drug action teams (DATs) in their role as commissioners of services as well as the direct delivery of services. The report includes definitions of the target client group and their needs; discusses key principles underpinning effective services and explores the key issues to address in delivering services.
Report presenting a comprehensive picture of the European situation on illicit drugs and medicines in relation to driving and summarising the studies which have been published on the subject since 1999.
One year ago the Scottish Government launched Scotland’s first drugs strategy since devolution. Central to the strategy was a new approach to tackling problem drug use based firmly on the concept of recovery. The action set out in the strategy reflects that tackling drug use requires action across a broad range of areas. This progress report takes the same approach.
Second annual report which sets out the progress made in 2002 across all 4 pillars of the Executive’s drugs strategy, namely, young people, communities, treatment and availability.
Herbal cannabis and cannabis resin are the most widely-misused illicit substances in the UK. In 2006, the Advisory Council on the Misuse of Drugs (ACMD) reviewed the classification of cannabis. One of the recommendations was that a further study should be carried out to determine the market share of different types of cannabis and their potencies. The Home Office funded the project.
First in a series of guides on developing and implementing Integrated Care Pathways (ICPs). While ICPs have been developed within health settings, there is a growing interest in their development across a range of treatment and social care settings to ensure that a co-ordinated, quality service is provided over the full continuum of care. Care pathways are designed to minimise delays, make best use of resources, and maximise quality of care.
This guide examines when and how integrated care pathways can be used to provide better care for people with drug problems.
These guidelines are a revision of 'Drug Misuse and Dependence: Guidelines on Clinical Management' published in 1991. A comprehensive set of guidance is provided for doctors in the assessment, treatment and management of drug users and drug misuse.
The former First Minister, Jack McConnell, announced a review of the place of methadone in drug treatment programmes on 6 March 2006 following the death of 2 year old Derek Doran. This review was conducted at the same time as the wider inter-departmental programme of work being undertaken across the Executive on children in drug abusing households.
There is increasing public, political and media interest in the use of methadone in drug treatment and in the perceived public risk posed by ‘leakage’ into the wider community, particularly in relation to children.
This review examines the impact of drug use upon families and carers and identifies their needs. It examines and describes the range of provision and methods of addressing the needs of families and carers. It gives particular attention to the development of family support groups. It also offers information about resources available to agencies, service providers and family support groups.